tazarotene 1 MG/ML Topical Foam
- RxCUI
- 1293451
- RxNorm name
- tazarotene 1 MG/ML Topical Foam
- Display name
- tazarotene 1 MG/ML Topical Foam
- Full name
- tazarotene 1 MG/ML Topical Foam
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:15
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FABIOR | TAZAROTENE | Mayne Pharma | ae0afed7-1d60-45fd-a08b-8db094618521 | 2026-03-03 | Warnings, Adverse reactions | 1293451 |
| tazarotene | TAZAROTENE | Mayne Pharma Inc. | 0e337598-f589-483f-a2ae-be7c319d7454 | 2024-06-04 | Warnings, Adverse reactions | 1293451 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ae0afed7-1d60-45fd-a08b-8db094618521 | tazarotene 0.1 % Topical Foam [PSN] · tazarotene 1 MG/ML Topical Foam [SCD] · tazarotene 0.1 % Topical Foam [SY] | 3 | 7 | These highlights do not include all the information needed to use FABIOR Foam safely and effectively. See full prescribing information for FABIOR Foam. FABIOR (tazarotene) Foam, 0 .1%, for topical use Initial U.S. Approval: 1997 | 20260303 |
| 0e337598-f589-483f-a2ae-be7c319d7454 | tazarotene 0.1 % Topical Foam [PSN] · tazarotene 1 MG/ML Topical Foam [SCD] · tazarotene 0.1 % Topical Foam [SY] | 3 | 3 | These highlights do not include all the information needed to use Tazarotene Foam safely and effectively. See full prescribing information for Tazarotene Foam. Tazarotene Foam, 0 .1%, for topical use Initial U.S. Approval: 1997 | 20240604 |